bi-78d3 has been researched along with Neoplasms* in 2 studies
1 review(s) available for bi-78d3 and Neoplasms
| Article | Year |
|---|---|
Targeting Extracellular Signal-Regulated Protein Kinase 1/2 (ERK1/2) in Cancer: An Update on Pharmacological Small-Molecule Inhibitors.
Topics: Extracellular Signal-Regulated MAP Kinases; Humans; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase Kinases; Neoplasms; Protein Kinase Inhibitors; Signal Transduction | 2022 |
1 other study(ies) available for bi-78d3 and Neoplasms
| Article | Year |
|---|---|
Unraveling the Design and Discovery of c-Jun N-Terminal Kinase Inhibitors and Their Therapeutic Potential in Human Diseases.
c-Jun N-terminal kinases (JNKs), members of the mitogen-activated protein kinase (MAPK) family, are encoded by three genes: Topics: Humans; JNK Mitogen-Activated Protein Kinases; MAP Kinase Signaling System; Neoplasms; Phosphorylation; Protein Isoforms | 2022 |